Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells
- 10 January 2011
- journal article
- Published by Elsevier BV in Mutation Research
- Vol. 706 (1-2), 28-35
- https://doi.org/10.1016/j.mrfmmm.2010.10.007
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Thymoquinone Induces Telomere Shortening, DNA Damage and Apoptosis in Human Glioblastoma CellsPLOS ONE, 2010
- RETRACTED: Thymoquinone poly (lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potentialBiochemical Pharmacology, 2010
- Drugging the PI3 Kinome: From Chemical Tools to Drugs in the ClinicCancer Research, 2010
- Tangeretin Sensitizes Cisplatin-Resistant Human Ovarian Cancer Cells through Downregulation of Phosphoinositide 3-Kinase/Akt Signaling PathwayCancer Research, 2009
- Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathwaysMolecular Cancer Therapeutics, 2008
- PTEN Autoregulates Its Expression by Stabilization of p53 in a Phosphatase-Independent MannerCancer Research, 2006
- PI3K/Akt and apoptosis: size mattersOncogene, 2003
- Cisplatin: mode of cytotoxic action and molecular basis of resistanceOncogene, 2003
- A novel DNA cleaving agent, 2,2′‐bis(2‐aminoethyl)‐4,4′‐bithiazole, induces thymocyte apoptosisIUBMB Life, 1996
- Thymoquinone fromEupatorium ayapanaPlanta Medica, 1993